| Description | DW-1350 is an antagonist of LTB4 receptor. |
| In vitro | DW-1350 displays inhibitory effects against osteoclast in terms of differentiation, fusion, formation, and bone absorption. |
| molecular weight | 453.6 |
| Molecular formula | C25H31N3O3S |
| CAS | 491577-61-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Kang JH, et al. 5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1expression. Bioorg Med Chem. 2015 Nov 1;23(21):7069-78. |